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Vitamin D deficiency is associated with a range of clinical disorders. To study the mechanisms involved and improve treatments,
animal models are tremendously useful. Current vitamin D deficient rat models have important practical limitations, including
time requirements when using, exclusively, a vitamin D deficient diet. More importantly, induction of hypovitaminosis D causes
significant fluctuations in parathyroid hormone (PTH) and mineral levels, complicating the interpretation of study results. To
overcome these shortcomings, we report the successful induction of vitamin D deficiency within three weeks, with stable serum
PTH and minerals levels, in Wistar rats. We incorporated two additional manoeuvres compared to a conventional diet. Firstly, the
vitamin D depleted diet is calcium (Ca) enriched, to attenuate the development of secondary hyperparathyroidism. Secondly, six
intraperitoneal injections of paricalcitol during the first two weeks are given to induce the rapid degradation of circulating vitamin
D metabolites. After three weeks, serum 25-hydroxyvitamin D
3
(25D) and 1,25-dihydroxyvitamin D
3
(1,25D) levels had dropped
below detection limits, with unchanged serum PTH, Ca, and phosphate (P) levels. Therefore, this model provides a useful tool to
examine the sole effect of hypovitaminosis D, in a wide range of research settings, without confounding changes in PTH, Ca, and P.
1. Introduction
Vitamin D deficiency is a worldwide problem [1] as it asso-
ciates with increased mortality for all causes. In the US adult
population, 42% is vitamin D deficient (25D serum levels
<50 nmol/L;<20 ng/mL) [2]. Due to the small content of vita-
minD in nonsupplemented food, circulating vitaminD levels
are mainly determined by the amount of sunlight exposure.
However, the high prevalence of vitamin D deficiency in the
otherwise healthy US population varies not only depending
upon seasonal changes, but also depending on cultural and
racial factors. Cultural factors that limit skin exposure to sun
light are clothing, age, sex, and the use of sunscreen protec-
tors. Racial factors include a darker skin pigmentation, which
limits conversion rates in spite of similar exposure to sun light
[1–4].Thehigh incidence of obesity in theUS population is an
additional determinant of vitaminDdeficiency, as circulating
levels are lower due to dilution in the fat mass [5].
The epidemiological association between vitamin D defi-
ciency and highmortality rates extends beyond the abnormal
mineral homeostasis that impairs bone mineralization due
to high serum levels of PTH. In fact, vitamin D deficiency
associates with an increased risk of hypertension, cardiovas-
cular disease, infectious and autoimmune diseases, glucose
intolerance, albuminuria, and cancer [6–11]. Clearly, adequate
strategies for vitaminD supplementation could help attenuate
the incidence of these disorders, as suggested by the recent
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but not ergocalciferol (vitamin D
2
), supplementation in
reducing mortality rates [12–14].
These observations urge for the need of animal models
to study the mechanistic link between vitamin D deficiency
and these clinical conditions. The most common models of
vitamin D deficiency using a dietary approach, a vitamin D
deficient diet, not only are time consuming and thus costly,
but also have major limitations for result interpretation,
specifically, due to the abnormalities in serum PTH, Ca, and
P levels, which develop from the prolonged time required to
achieve vitamin D deficiency due to the half-life of 15–18 days
of serum 25D [15, 16]. In addition, these strategies may fail to
achieve calcitriol deficiency in animals with normal kidney
function because serum calcitriol levels decrease below the
normal range only when serum 25D levels are lower than
4 ng/mL, that is, exclusively with severe vitamin D deficiency
[17].
Herein, two important modifications to the most com-
mon dietary approach were used to achieve vitamin D and
calcitriol deficiency within three weeks, while preventing
increases in PTH and abnormal serum Ca and P levels. The
first was the induction of renal CYP24A1, the enzyme respon-
sible for the degradation of endogenous 25D and calcitriol,
by administering the calcitriol analogue, paricalcitol. The
second was the maintenance of normal intestinal P and Ca
absorption and consequently normal serum PTH, through
feeding the rats a high Ca, P, and lactose diet, similar to the
rescue diet utilized in the vitamin D receptor (VDR) null
mice. This diet ensures vitamin D independent intestinal Ca
and P absorption [18, 19].
2. Methods
2.1. Animals and Experimental Design. Ten male Wistar rats
(Harlan CPB,Horst, Netherlands), aged 9-10 weeks, weighing
300–325 grams at the beginning of the study were used. The
rats underwent one-week acclimatization to the animal facil-
ity prior to the induction of vitamin D deficiency. Animals
were maintained under conventional housing conditions and
were given food and water ad libitum. From day one of
the experiment, the rats were fed a vitamin D deficient diet
(TD.87095 Brown C.C. Vit.D Defic, containing 20% lactose,
2% Ca, and 1.25% P). To induce CYP24A1 expression, to
accelerate the catabolism of endogenous 25D and calcitriol
stores, the rats received intraperitoneal injections of 32 ng
of 19-nor-1,25-dihydroxyvitamin D2 (paricalcitol; Zemplar,
kindly provided by AbbVie) on days 1, 3, 5, 8, 10, and 12.
The rats were weighed on days 1, 10, 15, and 22 during the
induction of vitamin D deficiency. Food consumption was
measured every day.The experimental protocol was approved
by the Animal Care Committee at the VUUniversityMedical
Center, Amsterdam.
2.2. Serum Analysis. Blood samples were drawn at days 1
and 22, respectively, before and after the initiation of the
induction of vitamin D deficiency. At both time points,
serum samples were analysed for 25D by competitive binding
protein assay (Diasorin, Stillwater, Minnesota, USA), 1,25D
by radioimmunoassay after immunoextraction (IDS, Tyne
and Wear, UK), PTH by ELISA (Scantibodies Laboratory,
Santee, CA), and Ca and P by colorimetric assays (Roche
diagnostics, Mannheim, Germany).
2.3. Statistical Analysis. Serummeasurements for the ten rats
studied are presented as a scatter plot. As most 25D and
1,25D measurements at day 21 were below detection limits,
the value of the detection level for each method was used
for the statistical analysis. The majority of vitamin D levels
after the intervention (both 1,25D and 25D) were below
the detection limit, precluding the use of paired 𝑡-testing.
Therefore, the nonparametricWilcoxon signed-rank test was
used to compare the differences in serum levels between days
1 and 22 using the IBM SPSS statistics 20 (Armonk, NY, US).
3. Results
Daily food intake was 20 gram per day (median; Inter
Quartiles (IQ) 19.3–20.8) which is similar to rats fed on
standard chow in terms of energy intake. In addition, there
were no obvious alterations in behaviour and in the changes
in body weight with time during the induction of vitamin
D deficiency, compared to those observed in the same strain
receiving a standard diet (data not shown).
Three weeks after the initiation of the induction of vita-
minDdeficiency, average 25D levels were below the detection
levels (15 nmol/L) in all animals, except for three which
showed a level for 25D just above detection limit (Figure 1(a)).
In addition, all animals had levels below detection limit
(30 pmol/L) for 1,25D (Figure 1(b)). Although the changes
of serum Ca levels (increased by a median of 0.095 (IQ
0.0525–0.15) mmol/L) and serum P levels (decreased by a
median decrease of 0.27 (IQ 0.0975–0.32)mmol/L) were both
statistically significant (𝑃 < 0.01), absolute changes were
mild and within normal range (Figures 1(c) and 1(d)) [20].
Moreover, importantly, there were no significant elevations
in serum PTH (Figure 1(e)).
4. Discussion
In this study, we show that vitamin D deficiency can be safely
and inexpensively induced in rats within three weeks with
negligible effects on PTH, Ca, and P levels. The major advan-
tage of this animal model is that it provides an extremely
useful platform to study the unbiased effects of vitamin D
deficiency and repletion, in a wide range of diseases that
are currently considered to be, at least, partially driven by
hypovitaminosis D. A key consideration is the undetectable
levels of serum calcitriol, which in individuals with normal
renal function only occur under conditions of severe vitamin
D deficiency (serum 25D below 4 ng/mL) [17].
Paricalcitol injections were given exclusively during the
first twoweeks to induceCYP24A1 expression to cause a rapid
depletion of the endogenous vitaminDmetabolites.Minimal,
if any, carry-over effects of paricalcitol activation of VDR
biological responses in serum samples analyzed for 25D and
1,25D one week after the cessation of paricalcitol injections
are expected. The rationale is that paricalcitol has a half-life
of approximately seven hours in healthy subjects and fourteen






















































































































Figure 1: Blood chemistries at days 1 and 21 after the induction of vitamin D deficiency. Scatter plot analyses of serum levels of 25D (a), 1,25D
(b), Ca (c), P (d), and PTH (e) before (day 1) and after three weeks (day 22) of starting the induction of vitamin D deficiency. Detection limits
were used to depict samples which were below detection levels. The median is represented by a straight line. ∗∗𝑃 < 0.01 for the statistical
significance of the changes in the parameter analyzed using the Wilcoxon signed-rank test.
hours in dialysed CKD stage 5 patients (data sheet, Zemplar).
Furthermore, although in rats formal pharmacokinetic data
on paricalcitol are lacking, studies on PTH suppression upon
a single dose of the calcitriol analogue 22-oxacalcitriol, with
a similarly short half-life to that of paricalcitol, revealed
that after 96 h there was no residual action of the analogue
on serum PTH but full depletion of serum calcitriol levels
[21]. These reports support the chosen period of one week
after cessation of paricalcitol injections to prevent carry-over
effects.
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Rats were fed a vitamin D depleted diet which contained
high levels of Ca (2%), P (1.25%), and 20% lactose, which
is commonly used to counteract the otherwise total absence
of VDR-dependent intestinal Ca and P absorption of the
VDR null mice, as lactose can increase the passive vitamin
D-independent Ca absorption in the intestine [18, 19]. The
use of a dietary Ca content (2%) higher than that in the
standard rat chow (1%) was directed to both normalize serum
Ca and prevent the development of hyperparathyroidism
during vitamin D deficiency. To counterbalance the higher
dietary Ca content, the P concentration in the diet was
increased from the usual 0.7% content to 1.25% [22]. Using
a similar diet, Kollenkirchen et al. showed that after six
weeks, male weanling rats had normocalcemia, normophos-
phatemia, normal PTH levels, and 25D and 1,25D levels
below 120 ng/mL and 20 pg/mL, respectively [23]. Johnson
and DeLuca achieved nondetectable 25D levels with nor-
mocalcemia and a slightly decline of phosphorus levels in
female rats after feeding a similar vitamin D depleted diet
(2% Ca, 1.25% P, and 20% lactose) for thirteen weeks [24].
Although these studies show that hypovitaminosis D can also
be induced by diet only, this requires a longer period of time,
therefore increasing costs and possibly causing discomfort to
the animals due to a longer exposure to abnormalities in Ca
and P homeostasis.
Using the described approach, undetectable levels of
both 25D and 1,25D were reached within three weeks, and
importantly, normal levels of potentially confounding factors
like serum PTH were maintained, along with only mild
changes in serum Ca and P.
The fine adjustment of dietary Ca and P and Ca/P ratio
is critical to avoid changes in Ca and P homeostasis that
could invalidate any conclusion from any model of vitamin
D deficiency, as shown by Fernandes et al. [15]. In fact,
in rats fed a vitamin D depleted diet with 0.4% Ca and
0.3% P for 6 weeks, serum Ca levels were significantly lower
while P and PTH concentrations were significantly elevated
compared to control animals fed standard chow containing
0.75% Ca, 0.66% P, and 2000 IU/kg vitamin D. In contrast,
rats switching from a vitamin D depleted diet with 0.4% Ca
and 0.3% P to a vitamin D depleted diet with 1.6% Ca and
20% lactose, after 5 weeks, could maintain normocalcemia.
However, serum PTH levels were significantly lower. P levels
were significantly lower than the animals fed for six weeks
on the low Ca and P vitamin D depleted diet but were not
statistically different from the control animals.
Undoubtedly, although vitamin D and calcitriol defi-
ciency will persist as long as rats are fed the vitamin D
deficient diet, a three-week period is a short follow-up time to
rule out the idea that signs of hyperparathyroidism or other
features of prolonged vitamin D deficiency will not occur
after a longer follow-up time. Whenever a longer exposure
to vitamin D deficiency is necessary, it is mandatory to
control for themaintenance of normal calcium, phosphate, or
PTH levels, to avoid compromising result interpretation.This
model, which also causes severe calcitriol deficiency, allows
discriminating the impact on outcomes of the correction of
active vitamin D deficiency exclusively.
5. Conclusion
In conclusion, we present a safe, simple, and cost effective
strategy to induce severe vitamin D and calcitriol deficiency
in rats without any major fluctuations in serum PTH, Ca,
and P levels. Therefore, this animal model could be used
to study the effects of exclusive hypovitaminosis D in many
different experimental settings to mimic human disorders
with only minimal potentially confounding effects of PTH
and minerals. This model is a very valuable tool, not only in
nephrology, but also in cancer, autoimmunity, cardiovascular,
bone, and infectious disease. The precise determination of
the exact role of exclusive vitamin D deficiency in all these
conditions may reinforce the clinical need to adequately
supplement this crucial vitamin.
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